%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Yuki Egawa, Chiemi Saigo, Yusuke Kito, Toshiaki Moriki, Tamotsu Takeuchi
Therapeutic potential of CPI-613 for targeting tumorous mitochondrial energy metabolism and inhibiting autophagy in clear cell sarcoma
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 13 0 R/Contents 14 0 R/TrimBox[0 0 612 792]>>
endobj
13 0 obj
[15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R]
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0198940.ref008)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0198940.ref009)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0198940.ref010)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0198940.ref011)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0198940.ref012)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0198940.ref013)>>
endobj
21 0 obj
<>/Border[0 0 0]/A 22 0 R>>
endobj
22 0 obj
<>
endobj
14 0 obj
[23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R]
endobj
23 0 obj
<>stream
q
0.83 0.64 0.02 0 k
373.2661 693.2976 m
378.0283 693.2976 l
h
f*
382.4504 693.2976 m
387.2126 693.2976 l
h
f*
555.3071 603.4961 m
564.7748 603.4961 l
h
f*
200.0126 590.5134 m
209.537 590.5134 l
h
f*
302.6268 564.548 m
312.1512 564.548 l
h
f*
343.6724 387.7228 m
353.1969 387.7228 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 200.0125 707.4141 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(trials)Tj
2.194 0 Td
(on)Tj
1.2755 0 Td
(CPI-613)Tj
3.5603 0 Td
(have)Tj
2.0636 0 Td
(been)Tj
2.1203 0 Td
(completed)Tj
4.405 0 Td
(for)Tj
1.389 0 Td
(hematological)Tj
5.8167 0 Td
(malignancies)Tj
5.4595 0 Td
(and)Tj
1.7291 0 Td
(pancreatic)Tj
4.3653 0 Td
(cancer,)Tj
-34.3783 -1.3039 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4683 0 Td
(drug)Tj
2.1146 0 Td
(was)Tj
1.6951 0 Td
(well)Tj
1.8199 0 Td
(tolerated)Tj
3.753 0 Td
(in)Tj
1.0375 0 Td
(patients)Tj
3.3675 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2586 0 Td
(9)Tj
0 g
(].)Tj
-17.0474 -1.2982 Td
(In)Tj
1.0998 0 Td
(this)Tj
1.6668 0 Td
(report,)Tj
2.9253 0 Td
(we)Tj
1.3209 0 Td
(describe)Tj
3.515 0 Td
(the)Tj
1.4626 0 Td
(putative)Tj
3.4299 0 Td
(suppressive)Tj
4.7962 0 Td
(efficacy)Tj
3.2145 0 Td
(of)Tj
1.0091 0 Td
(CPI-613)Tj
3.549 0 Td
(on)Tj
1.2642 0 Td
(the)Tj
1.4627 0 Td
(local)Tj
2.0693 0 Td
(and)Tj
1.7234 0 Td
(met-)Tj
-35.7049 -1.2983 Td
(astatic)Tj
2.7325 0 Td
(growth)Tj
3.0784 0 Td
(of)Tj
1.0148 0 Td
(CCS)Tj
2.0183 0 Td
(using)Tj
2.3924 0 Td
(a)Tj
0.652 0 Td
(novel)Tj
2.3981 0 Td
(murine)Tj
3.1804 0 Td
(model)Tj
2.7439 0 Td
(with)Tj
1.9956 0 Td
(high)Tj
2.0069 0 Td
(rates)Tj
2.109 0 Td
(of)Tj
1.0148 0 Td
(metastasis.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 639.6094 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Materials)Tj
4.5071 0 Td
(and)Tj
1.989 0 Td
(methods)Tj
/F12 1 Tf
-6.4961 -1.5023 Td
(HS-MM)Tj
3.5953 0 Td
(clear)Tj
2.2204 0 Td
(cell)Tj
1.6347 0 Td
(sarcoma)Tj
3.7134 0 Td
(cell)Tj
1.6347 0 Td
(line)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 604.5732 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(A)Tj
0.9014 0 Td
(CCS)Tj
2.0239 0 Td
(cell)Tj
1.559 0 Td
(line,)Tj
1.9332 0 Td
(HS-MM,)Tj
3.8211 0 Td
(was)Tj
1.7008 0 Td
(previously)Tj
4.3483 0 Td
(established)Tj
4.5978 0 Td
(and)Tj
1.7291 0 Td
(characterized)Tj
5.5616 0 Td
(in)Tj
1.0318 0 Td
(our)Tj
1.627 0 Td
(laboratory)Tj
4.354 0 Td
([)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
-35.189 -1.2982 Td
(11)Tj
0 g
(].)Tj
1.7347 0 Td
(HS-MM)Tj
3.6 0 Td
(cells)Tj
1.9219 0 Td
(harbor)Tj
2.9367 0 Td
(a)Tj
0.6519 0 Td
(canonical)Tj
4.0536 0 Td
(genetic)Tj
3.0727 0 Td
(background)Tj
5.023 0 Td
(with)Tj
2.0012 0 Td
(t\(12;22\)\(q13;q12\))Tj
7.1489 0 Td
(of)Tj
1.0148 0 Td
(clear)Tj
2.1147 0 Td
(cell)Tj
-35.2741 -1.2983 Td
(sarcoma,)Tj
3.7927 0 Td
(which)Tj
2.6532 0 Td
(results)Tj
2.8063 0 Td
(in)Tj
1.0374 0 Td
(an)Tj
/F13 1 Tf
1.2019 0 Td
[()15()]TJ
2.1657 0 Td
[()28()]TJ
2.16 0 Td
[()11()12( )6(\n)12()12( )13()]TJ
3.1974 0 Td
[()11(\r)20()12()11()2()12( )]TJ
3.0047 0 Td
[()]TJ
0.686 0 Td
[()15()8()6()-4()7()15()3()22()7()12( )13()]TJ
8.0504 0 Td
[()7(\r)20()16( )-3()1(\r)-9()10()12()7()4()11( )]TJ
5.2554 0 Td
[()9()6()]TJ
-36.0111 -1.2982 Td
[()11()11(\r)]TJ
1.3436 0 Td
[()]TJ
0.6859 0 Td
[()89()]TJ
/F6 1 Tf
3.0955 0 Td
(fusion)Tj
2.7155 0 Td
(gene)Tj
2.0806 0 Td
([)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(].)Tj
2.0807 0 Td
(Cells)Tj
2.16 0 Td
(were)Tj
2.1203 0 Td
(cultured)Tj
3.5659 0 Td
(with)Tj
1.9956 0 Td
(Dulbecco's)Tj
4.5921 0 Td
(modified)Tj
3.8494 0 Td
(Eagle's)Tj
2.931 0 Td
(medium)Tj
-33.2161 -1.304 Td
(\(DMEM;)Tj
3.8777 0 Td
(Gibco)Tj
2.6362 0 Td
(Life)Tj
1.7405 0 Td
(Technologies,)Tj
5.7543 0 Td
(Grand)Tj
2.8176 0 Td
(Island,)Tj
2.9027 0 Td
(NY,)Tj
1.8141 0 Td
(USA\))Tj
2.4548 0 Td
(containing)Tj
4.5297 0 Td
(10%)Tj
1.9276 0 Td
(heat-inactivated)Tj
-30.4552 -1.2982 Td
(fetal)Tj
1.9105 0 Td
(bovine)Tj
2.9253 0 Td
(serum.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 510.8031 cm
BT
/F12 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(CPI-613)Tj
3.6945 0 Td
(and)Tj
1.7905 0 Td
(chloroquine,)Tj
5.5087 0 Td
(autolysosome)Tj
5.9056 0 Td
(detection,)Tj
4.3465 0 Td
(and)Tj
1.7953 0 Td
(double)Tj
3.0709 0 Td
(staining)Tj
-26.112 -1.1669 Td
(with)Tj
2.0787 0 Td
(annexin)Tj
3.5575 0 Td
(V)Tj
0.926 0 Td
(and)Tj
1.7906 0 Td
(propidium)Tj
4.748 0 Td
(iodide)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 479.7921 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(CPI-613)Tj
3.5602 0 Td
(and)Tj
1.7292 0 Td
(chloroquine)Tj
5.0739 0 Td
(were)Tj
2.126 0 Td
(purchased)Tj
4.3313 0 Td
(from)Tj
2.2054 0 Td
(AdooQ)Tj
3.1918 0 Td
(BioScience)Tj
4.5637 0 Td
(\(Irvine,)Tj
3.1861 0 Td
(CA,)Tj
1.7972 0 Td
(USA\))Tj
2.4548 0 Td
(and)Tj
-34.2196 -1.2982 Td
(Nacalai)Tj
3.1917 0 Td
(Tesque)Tj
3.0728 0 Td
(\(Tokyo,)Tj
3.3618 0 Td
(Japan\),)Tj
3.0501 0 Td
(respectively.)Tj
5.1137 0 Td
(Necrostatin-1)Tj
5.7146 0 Td
(was)Tj
1.6951 0 Td
(purchased)Tj
4.337 0 Td
(from)Tj
2.2053 0 Td
(Abcam)Tj
3.0898 0 Td
(\(Cam-)Tj
-34.8319 -1.2983 Td
(bridge,)Tj
3.0047 0 Td
(UK\).)Tj
-1.8085 -1.3039 Td
(To)Tj
1.3379 0 Td
(detect)Tj
2.6192 0 Td
(autolysosomes,)Tj
6.2532 0 Td
(we)Tj
1.3266 0 Td
(employed)Tj
4.1386 0 Td
(the)Tj
1.4683 0 Td
(DALGreen)Tj
4.6601 0 Td
(agent)Tj
2.3924 0 Td
(\(Dojindo)Tj
3.9118 0 Td
(Co.,)Tj
1.8369 0 Td
(Kumamoto,)Tj
-31.1412 -1.2983 Td
(Japan\))Tj
2.8232 0 Td
(according)Tj
4.1839 0 Td
(the)Tj
1.4741 0 Td
(manufacturer's)Tj
6.2645 0 Td
(protocol.)Tj
3.8211 0 Td
(Briefly,)Tj
3.0727 0 Td
(DALGreen,)Tj
4.8869 0 Td
(which)Tj
2.6532 0 Td
(is)Tj
0.8447 0 Td
(a)Tj
0.6577 0 Td
(small)Tj
2.3244 0 Td
(hydropho-)Tj
-33.0064 -1.2982 Td
(bic)Tj
1.4173 0 Td
(molecule,)Tj
4.0592 0 Td
(passes)Tj
2.6815 0 Td
(the)Tj
1.4683 0 Td
(cell)Tj
1.5591 0 Td
(surface)Tj
3.0501 0 Td
(membrane)Tj
4.5637 0 Td
(of)Tj
1.0148 0 Td
(live)Tj
1.6157 0 Td
(cells)Tj
1.9162 0 Td
(and)Tj
1.7348 0 Td
(is)Tj
0.8448 0 Td
(incorporated)Tj
5.4198 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(autopha-)Tj
-33.8511 -1.3039 Td
(gosome.)Tj
3.5262 0 Td
(After)Tj
2.2847 0 Td
(a)Tj
0.6577 0 Td
(lysosome)Tj
3.9004 0 Td
(fuses)Tj
2.177 0 Td
(with)Tj
2.0013 0 Td
(the)Tj
1.4683 0 Td
(autophagosome,)Tj
6.7748 0 Td
(the)Tj
1.4683 0 Td
(incorporated)Tj
5.4141 0 Td
(DALGreen)Tj
4.6602 0 Td
(begins)Tj
-34.333 -1.2983 Td
(to)Tj
1.0261 0 Td
(fluoresce)Tj
3.787 0 Td
(as)Tj
1.0148 0 Td
(the)Tj
1.4741 0 Td
(acidity)Tj
2.8913 0 Td
(increases)Tj
3.8324 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(],)Tj
2.0749 0 Td
(and)Tj
1.7348 0 Td
(this)Tj
1.6725 0 Td
(was)Tj
1.7007 0 Td
(visualized)Tj
4.1386 0 Td
(under)Tj
2.6192 0 Td
(a)Tj
0.652 0 Td
(confocal)Tj
3.5999 0 Td
(fluorescence)Tj
-32.2183 -1.2983 Td
(microscope)Tj
4.8415 0 Td
(\(Leica)Tj
2.6419 0 Td
(TCS)Tj
1.9729 0 Td
(SP8;)Tj
1.9559 0 Td
(Leica)Tj
2.3073 0 Td
(Corporation,)Tj
5.4369 0 Td
(Germany\))Tj
4.3256 0 Td
(and)Tj
1.7291 0 Td
(analyzed)Tj
3.7021 0 Td
(with)Tj
2.0012 0 Td
(a)Tj
0.652 0 Td
(Guava)Tj
2.7836 0 Td
(Easy-)Tj
-34.35 -1.3039 Td
(Cyte)Tj
2.0579 0 Td
(cell)Tj
1.559 0 Td
(analyzer)Tj
3.549 0 Td
(\(Hayward,)Tj
4.456 0 Td
(CA,)Tj
1.7915 0 Td
(USA\).)Tj
-12.2172 -1.2983 Td
(Cells)Tj
2.1599 0 Td
(were)Tj
2.126 0 Td
(also)Tj
1.7688 0 Td
(stained)Tj
3.0784 0 Td
(with)Tj
1.9956 0 Td
(a)Tj
0.6576 0 Td
(fluorescein)Tj
4.6035 0 Td
(isothiocyanate)Tj
5.9754 0 Td
(\(FITC\)-conjugated)Tj
7.8009 0 Td
(Annexin)Tj
3.7077 0 Td
(V)Tj
0.9127 0 Td
(and)Tj
-35.9827 -1.2982 Td
(propidium)Tj
4.541 0 Td
(iodide)Tj
2.7383 0 Td
(\(PI\))Tj
1.8028 0 Td
(\(PromoCell)Tj
4.9039 0 Td
(GmbH,)Tj
3.2542 0 Td
(Heidelberg,)Tj
4.8642 0 Td
(Germany\))Tj
4.3313 0 Td
(followed)Tj
3.6453 0 Td
(by)Tj
1.1849 0 Td
(analysis)Tj
3.3278 0 Td
(with)Tj
1.9956 0 Td
(a)Tj
-36.5893 -1.3039 Td
(confocal)Tj
3.5943 0 Td
(fluorescence)Tj
5.1873 0 Td
(microscope)Tj
4.8416 0 Td
(and)Tj
1.7291 0 Td
(cell)Tj
1.559 0 Td
(analyzer.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 294.9732 cm
BT
/F12 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Xenoplantation)Tj
6.7795 0 Td
(and)Tj
1.7953 0 Td
(CPI-613)Tj
3.6898 0 Td
(treatment)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 278.022 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(The)Tj
1.7801 0 Td
(experimental)Tj
5.4595 0 Td
(protocol)Tj
3.6 0 Td
(was)Tj
1.6951 0 Td
(approved)Tj
3.9741 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.474 0 Td
(Animal)Tj
3.2202 0 Td
(Care)Tj
2.1089 0 Td
(Committee)Tj
4.7395 0 Td
(of)Tj
1.0148 0 Td
(Gifu)Tj
2.0183 0 Td
(Graduate)Tj
-32.2637 -1.3039 Td
(School)Tj
2.9083 0 Td
(of)Tj
1.0148 0 Td
(Gifu,)Tj
2.2393 0 Td
(Japan)Tj
2.4832 0 Td
(\(approval)Tj
4.0421 0 Td
(No.)Tj
1.6895 0 Td
(2780\).)Tj
3.2031 0 Td
(SCID-beige)Tj
4.8756 0 Td
(\(CB17.Cg-PrkdcscidLystbg-J/)Tj
11.8317 0 Td
(CrlCrlj\))Tj
-34.2876 -1.2982 Td
(mice)Tj
2.1543 0 Td
(were)Tj
2.1203 0 Td
(purchased)Tj
4.3313 0 Td
(from)Tj
2.2053 0 Td
(Charles)Tj
3.2485 0 Td
(River)Tj
2.3584 0 Td
(Laboratories)Tj
5.2384 0 Td
(Japan)Tj
2.4831 0 Td
(\(Sizuoka,)Tj
3.9062 0 Td
(Japan\))Tj
2.8232 0 Td
(and)Tj
1.7292 0 Td
(were)Tj
2.1203 0 Td
(housed)Tj
-34.7185 -1.2983 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(Animal)Tj
3.2201 0 Td
(facility)Tj
2.897 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(Gifu)Tj
2.0183 0 Td
(Graduate)Tj
3.9514 0 Td
(School)Tj
2.9084 0 Td
(of)Tj
1.0148 0 Td
(Gifu,)Tj
2.245 0 Td
(Gifu,)Tj
2.2394 0 Td
(Japan.)Tj
2.7099 0 Td
(Mice)Tj
2.228 0 Td
(were)Tj
2.1203 0 Td
(monitored)Tj
-32.5415 -1.3039 Td
(for)Tj
1.3832 0 Td
(signs)Tj
2.2224 0 Td
(of)Tj
1.0148 0 Td
(distress)Tj
3.1918 0 Td
(and)Tj
1.7291 0 Td
(were)Tj
2.126 0 Td
(euthanized)Tj
4.6091 0 Td
(humanely)Tj
4.2009 0 Td
(according)Tj
4.1896 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4684 0 Td
(guidelines)Tj
4.2802 0 Td
(for)Tj
1.3833 0 Td
(housing)Tj
-32.8249 -1.2983 Td
(mice)Tj
2.1543 0 Td
(in)Tj
1.0318 0 Td
(animal)Tj
2.9707 0 Td
(facility)Tj
2.897 0 Td
(\(100%)Tj
2.7495 0 Td
(CO)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 332.107 211.3511 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 337.8897 212.9952 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(inhalation)Tj
4.2972 0 Td
(followed)Tj
3.651 0 Td
(by)Tj
1.1793 0 Td
(cervical)Tj
3.2654 0 Td
(dislocation\).)Tj
5.1704 0 Td
(We)Tj
1.6101 0 Td
(did)Tj
1.542 0 Td
(not)Tj
-34.503 -1.2982 Td
(observe)Tj
3.2655 0 Td
(any)Tj
1.6611 0 Td
(signs)Tj
2.2224 0 Td
(of)Tj
1.0147 0 Td
(distress,)Tj
3.4129 0 Td
(including)Tj
4.0421 0 Td
(weight)Tj
2.8857 0 Td
(loss,)Tj
1.9218 0 Td
(appetite)Tj
3.4016 0 Td
(loss,)Tj
1.9162 0 Td
(or)Tj
1.0998 0 Td
(tumor)Tj
2.744 0 Td
(ulceration,)Tj
4.49 0 Td
(in)Tj
1.0375 0 Td
(any)Tj
-35.1153 -1.3039 Td
(groups)Tj
2.9707 0 Td
(of)Tj
1.0148 0 Td
(mice)Tj
2.1487 0 Td
(in)Tj
1.0374 0 Td
(this)Tj
1.6725 0 Td
(study.)Tj
2.6192 0 Td
(No)Tj
1.4626 0 Td
(animal)Tj
2.9706 0 Td
(died)Tj
1.9616 0 Td
(during)Tj
2.931 0 Td
(the)Tj
1.4683 0 Td
(experiment)Tj
4.7792 0 Td
(except)Tj
2.7723 0 Td
(when)Tj
2.4037 0 Td
(sacrificed)Tj
4.0025 0 Td
(at)Tj
-36.2151 -1.2983 Td
(the)Tj
1.4684 0 Td
(experimental)Tj
5.4595 0 Td
(end)Tj
1.7177 0 Td
(point.)Tj
-7.4494 -1.2983 Td
(SCID-beige)Tj
4.8756 0 Td
(\(CB17.Cg-PrkdcscidLystbg-J/)Tj
11.8316 0 Td
(CrlCrlj\))Tj
3.3732 0 Td
(mice)Tj
2.1544 0 Td
(were)Tj
2.1259 0 Td
(purchased)Tj
4.3313 0 Td
(from)Tj
2.2054 0 Td
(Charles)Tj
3.2485 0 Td
(River)Tj
-35.3421 -1.2982 Td
(Laboratories)Tj
5.2384 0 Td
(Japan)Tj
2.4831 0 Td
(\(Sizuoka,)Tj
3.9062 0 Td
(Japan\).)Tj
-10.4315 -1.3039 Td
(Mice)Tj
2.2281 0 Td
(were)Tj
2.1259 0 Td
(injected)Tj
3.3846 0 Td
(with)Tj
2.0012 0 Td
(2.5)Tj
/F14 1 Tf
1.3947 0 Td
[()]TJ
/F6 1 Tf
0.788 0 Td
(10)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 340.7244 139.4645 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(7)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 346.507 134.9858 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(HS-MM)Tj
3.5943 0 Td
(cells)Tj
1.9218 0 Td
(into)Tj
1.8425 0 Td
(the)Tj
1.4684 0 Td
(aponeuroses)Tj
5.2044 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(thighs.)Tj
2.8913 0 Td
(Tumor)Tj
-34.0551 -1.2982 Td
(volume)Tj
3.1975 0 Td
(was)Tj
1.7007 0 Td
(measured)Tj
4.1046 0 Td
(by)Tj
1.1848 0 Td
(calipers)Tj
3.2655 0 Td
(using)Tj
2.3867 0 Td
(following)Tj
3.9798 0 Td
(equation:)Tj
3.9572 0 Td
(tumor)Tj
2.7439 0 Td
(volumes)Tj
3.5603 0 Td
(\(mm)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 520.611 126.4251 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(3)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 524.1826 122.0031 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(\))Tj
0.5612 0 Td
(=)Tj
0.7994 0 Td
(4/3)Tj
/F14 1 Tf
1.5023 0 Td
[()]TJ
/F6 1 Tf
([a/)Tj
-35.2797 -1.2982 Td
(2])Tj
/F14 1 Tf
[()]TJ
/F6 1 Tf
([b/2])Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 233.8015 113.4425 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(2)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 237.3165 109.0204 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(,)Tj
0.4478 0 Td
(where)Tj
2.6476 0 Td
(`a')Tj
1.0941 0 Td
(and)Tj
1.7348 0 Td
(`b')Tj
1.1622 0 Td
(correspond)Tj
4.7792 0 Td
(to)Tj
1.0261 0 Td
(the)Tj
1.4684 0 Td
(longest)Tj
3.0727 0 Td
(and)Tj
1.7291 0 Td
(shortest)Tj
3.3676 0 Td
(diameter.)Tj
-25.0637 -1.3039 Td
(Mice)Tj
2.228 0 Td
(were)Tj
2.1259 0 Td
(intraperitoneally)Tj
6.8768 0 Td
(injected)Tj
3.3845 0 Td
(with)Tj
2.0013 0 Td
(CPI-613)Tj
3.5603 0 Td
(\(25)Tj
1.508 0 Td
(mg/kg\))Tj
3.1351 0 Td
(and)Tj
1.7348 0 Td
(chloroquine)Tj
5.074 0 Td
(\(50)Tj
1.5137 0 Td
(mg/kg\),)Tj
-34.3386 -1.2982 Td
(two)Tj
1.7064 0 Td
(days)Tj
2.0013 0 Td
(a)Tj
0.6518 0 Td
(week)Tj
2.2451 0 Td
(for)Tj
1.3889 0 Td
(two)Tj
1.7065 0 Td
(weeks,)Tj
2.8346 0 Td
(when)Tj
2.4038 0 Td
(tumor)Tj
2.7439 0 Td
(volumes)Tj
3.5603 0 Td
(reached)Tj
3.3505 0 Td
(approximately)Tj
5.9754 0 Td
(2mm)Tj
ET
Q
q
1 j
1 J
0 w
7.4999 0 0 6.6659 526.9039 87.4204 cm
BT
/F6 1 Tf
1 TL
-0.0053 Tc
0 0 Td
(3)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 530.4188 82.9984 cm
BT
/F6 1 Tf
1 TL
-0.004 Tc
0 0 Td
(.)Tj
0.4478 0 Td
(One)Tj
1.9389 0 Td
(week)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 392.0881 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Therap)Tj
3.111 0 Td
(eutic)Tj
2.2961 0 Td
(potentia)Tj
3.4866 0 Td
(l)Tj
0.4394 0 Td
(of)Tj
1.0346 0 Td
(CPI-613)Tj
3.8339 0 Td
(in)Tj
0.978 0 Td
(clear)Tj
2.3457 0 Td
(cell)Tj
1.6795 0 Td
(sarcoma)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01989)Tj
4.089 0 Td
(40)Tj
0 g
2.0906 0 Td
(June)Tj
2.3528 0 Td
(7,)Tj
1.0417 0 Td
(2018)Tj
35.5113 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
24 0 obj
<>stream
endstream
endobj
25 0 obj
<>stream
endstream
endobj
26 0 obj
<>stream
endstream
endobj
27 0 obj
<>stream
endstream
endobj
28 0 obj
<>stream
endstream
endobj
29 0 obj
<>stream
endstream
endobj
30 0 obj
<>stream
endstream
endobj
31 0 obj
<>stream
endstream
endobj
32 0 obj
<>stream
endstream
endobj
33 0 obj
<>stream
BT
66.402 0 Td
(10)Tj
ET
Q
endstream
endobj
34 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 12 0 R/Annots 36 0 R/Contents 37 0 R/TrimBox[0 0 612 792]>>
endobj
35 0 obj
<>
endobj
38 0 obj
<>stream
/CIDInit/ProcSet findresource begin
12 dict begin begincmap
/CMapName/Adobe-Identity-UCS def
/CIDSystemInfo<>def
/CMapType 2 def
1 begincodespacerange
<0000>
endcodespacerange
8 beginbfchar
<000A><0027>
<0010><002D>
<0016><0033>
<0018><0035>
<0024><0041>
<0026><0043>
<002A><0047>
<0037><0054>
endbfchar
endcmap
CMapName currentdict /CMap defineresource pop end end
endstream
endobj
39 0 obj
<>/FontDescriptor 40 0 R/DW 600>>
endobj
40 0 obj
<>
endobj
41 0 obj
<>stream
cvt a &@ fpgm62 h glyf1I 8
headg 6hhea{<